CN115444912A - 一种治疗痤疮的组合物及其制备方法 - Google Patents
一种治疗痤疮的组合物及其制备方法 Download PDFInfo
- Publication number
- CN115444912A CN115444912A CN202211089689.0A CN202211089689A CN115444912A CN 115444912 A CN115444912 A CN 115444912A CN 202211089689 A CN202211089689 A CN 202211089689A CN 115444912 A CN115444912 A CN 115444912A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- composition
- water
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 67
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 238000011282 treatment Methods 0.000 claims description 18
- 239000011550 stock solution Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 241001071917 Lithospermum Species 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- 241001180876 Saposhnikovia Species 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 8
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 8
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 8
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 8
- 229940116229 borneol Drugs 0.000 claims description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 240000000233 Melia azedarach Species 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 229940037003 alum Drugs 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003809 water extraction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 14
- 230000008961 swelling Effects 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 208000020154 Acnes Diseases 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 17
- 208000003251 Pruritus Diseases 0.000 description 14
- 238000003745 diagnosis Methods 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 206010037844 rash Diseases 0.000 description 10
- 208000010201 Exanthema Diseases 0.000 description 9
- 201000005884 exanthem Diseases 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000001815 facial effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 238000002405 diagnostic procedure Methods 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012374 Depressed mood Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 241000212749 Zesius chrysomallus Species 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 206010035114 pityriasis rosea Diseases 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010049290 Feminisation acquired Diseases 0.000 description 1
- 208000034793 Feminization Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 239000010242 baoji Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- -1 retinoids Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000000438 stratum basale Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000002311 subsequent effect Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗痤疮的组合物及其制备方法。所述治疗痤疮的组合物是将中药提取物活性成分苦参、百部、蛇床子、白鲜皮、侧柏叶等提取物与其它配方成分及配方体系配合,然后通过提取,所得组合物提取物活性成分能够有效消炎祛痘、治疗皮肤疾病,达到祛痘消肿、消炎抑菌以及改善肌肤环境等功效。
Description
技术领域
本发明属于医药技术领域,具体涉及一种治疗痤疮的组合物及其制备方法。
背景技术
痤疮,是一种由毛囊及皮脂腺阻塞,导致的慢性炎症性皮肤问题。研究发现超过95%的人会有不同程度痤疮发生。以炎性皮损病况更为严峻,极易留下疤痕。由于油脂大量分泌滋生大量螨虫等因素,也极易复发。针对不同严重程度,现有的药物多具有刺激性、致敏性、耐药性等副作用。大量的痤疮患者不仅长期忍受着疼痛和不适,还忍受着痤疮对他们容貌、生活产生的影响,这些影响甚至可能导致失眠、抑郁、焦虑、注意力缺陷障碍而影响患者心理健康。依据痤疮皮损的严重程度,将痤疮分为:轻度(Ⅰ级):仅有粉刺;中度(Ⅱ级):有炎性丘疹;中度(Ⅲ级):出现脓疱;重度(Ⅳ级):有结节、囊肿。
针对以上分级,国际痤疮治疗指南建议的药物有维甲酸类药物、抗生素、口服激素等。这些药物多具有刺激性、致敏性、耐药性等副作用,痤疮复发会加重皮损程度,加深色素沉积。长期治疗可能会引起色素沉积、男子女性化及停药反应等不良反应。目前祛痘护肤品效果不显著,治标不治本,有刺激性。因此治疗痤疮、修复皮损并从根源上杜绝复发是治疗痤疮的三大需求。中药治疗痤疮在安全性方面具有独特的优越性。长期使用西药所带来的副作用使得大量痤疮患者将目光转向中药,以寻找一种安全温和的治疗方式。本发明基于临床经验,研发出一种针对Ⅱ、Ⅲ、Ⅳ级痤疮患者的中药组合物,并将内服药汤剂改良成敷于患处的外用涂剂。中药组合物在使用时软化毛囊角化层,渗透药物,从而有利于皮肤毛囊通畅和皮脂顺利排出,减少丘疹、脓疙、囊肿的形成,使皮肤环境更加清洁,对痤疮起到明显改善作用。
发明内容
本发明的中药组合物在有较长的临床应用经验,安全性和有效性可以得到保障。产品采用纯汉方提取物,不仅能够快速地治疗炎症性痤疮,还可以消炎杀菌抑制痤疮复发,具有副反应轻、刺激性弱,治疗成本低的特点。
一种治疗痤疮的组合物,其特征在于包含以下重量份的组份:
苦参1-5份、百部1-6份、蛇床子0.5-5份、白鲜皮1-3份、侧柏叶1-4份、川楝子1-1.5份、防风1-4份、紫草1-5份、地肤子1-1.5份、土茯苓1-3份。
优选的是,本发明治疗痤疮的组合物,包含以下重量份的组份:
苦参2-4份、百部2-5份、蛇床子2-5份、白鲜皮1-3份、侧柏叶2-3份、川楝子1-1.5份、防风2-4份、紫草3-5份、地肤子1-1.5份、薄荷2-6份、冰片1-4份。
优选的是,本发明治疗痤疮的组合物,包含以下重量份的组份:
苦参2-4份、百部1-3份、蛇床子2-4份、白鲜皮1-3份、侧柏叶2.5-3.5份、防风2-4份、紫草2-4份、地肤子1-1.5份、蜂房2-3份、皂刺1-3份、薄荷4-6份、冰片1-3份、白矾1-3份。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S11)将所述各组份清洗后放入在砂锅中,加入没过成分的纯净水浸泡;
步骤S12)浸泡半小时后,加热水提2小时;
步骤S13)倒出水提液,再次加入同量纯净水,加热水提1.5小时;
步骤S14)合并两次水提液,静置后过滤上清液,浓缩至原1/3,制得原液。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S21)将所述成分混合均匀,取30 g,浸泡入1500 mL 50%乙醇中;
步骤S22)闪式提取3 min,滤除提取液;
步骤S23)提取液用0.22 μm微孔滤膜过滤,制得原液。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S31)购买所述成分主要提取物;
步骤S32)按其说明书,换算出生药量进行配比;
步骤S33)用换算后生药适宜量的50%乙醇溶解,制得原液。
苦参:根含苦参碱和金雀花碱等,入药有清热利湿,抗菌消炎,健胃驱虫之效,常用作治疗皮肤瘙痒,神经衰弱,消化不良及便秘等症;种子可作农药;茎皮纤维可织麻袋等。
百部:润肺下气止咳,杀虫。用于新久咳嗽,肺痨咳嗽,百日咳;外用于头虱,体虱,蛲虫病,阴部骚痒。蜜百部润肺止咳。用于阴虚劳嗽。配合紫菀、款冬、黄芩、白及等同用。
蛇床子:燥湿,祛风,杀虫,温肾壮阳。用于阳痿、宫冷、寒湿带下、湿痹腰痛;外治外阴湿疹、妇人阴痒、滴虫性阴道炎。
白鲜皮:风热湿毒所致的风疹;湿疹;疥癣;黄疸;湿热痹。
侧柏叶:用于吐血,衄血,咯血,便血,崩漏下血,肺热咳嗽,血热脱发,须发早白
川楝子:舒肝行气止痛,驱虫。用于胸胁、脘腹胀痛,疝痛,虫积腹痛。
防风:用于外感表证,风疹瘙痒,风湿痹痛,破伤风证,脾虚湿盛。
紫草:凉血,活血,清热,解毒。治温热斑疹,湿热黄疸,紫癜,吐、衄、尿血,淋浊,热结便秘,烧伤,湿疹,丹毒,痈疡。
地肤子:利小便,清湿热。治小便不利,淋病,带下,疝气,风疹,疮毒,疥癣,阴部湿痒。
土茯苓:解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疗疔疮,痈肿,瘰疬,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。
本发明已完成的皮肤刺激性实验,本品无刺激性,温和耐受。给本品1天以及7天豚鼠皮肤外观、病理切片均显示无明显刺激性变化。
结果显示:连续给予组合物后空白组豚鼠皮肤组织和连续给卡波姆后空白组豚鼠皮肤组织角质层完整,基底层未见明显增厚且没有明显的炎症细胞募集。与连续给予卡波姆后创伤组豚鼠皮肤组织相比,连续给予组合物后创伤组豚鼠皮肤组织角质层未发生更为严重的损伤,基底层未发生更严重的增厚,且炎症细胞较少。结果表明,该组合物对豚鼠的正常完整和受损皮肤均无明显刺激性。
具体实施方式
下面参照具体实施例对本发明的技术方案作进一步说明:
一种治疗痤疮的组合物,其特征在于包含以下重量份的组份:
苦参1-5份、百部1-6份、蛇床子0.5-5份、白鲜皮1-3份、侧柏叶1-4份、川楝子1-1.5份、防风1-4份、紫草1-5份、地肤子1-1.5份、土茯苓1-3份。
一种治疗痤疮的组合物,包含以下重量份的组份:
苦参2-4份、百部2-5份、蛇床子2-5份、白鲜皮1-3份、侧柏叶2-3份、川楝子1-1.5份、防风2-4份、紫草3-5份、地肤子1-1.5份、薄荷2-6份、冰片1-4份。
一种治疗痤疮的组合物,包含以下重量份的组份:
苦参2-4份、百部1-3份、蛇床子2-4份、白鲜皮1-3份、侧柏叶2.5-3.5份、防风2-4份、紫草2-4份、地肤子1-1.5份、蜂房2-3份、皂刺1-3份、薄荷4-6份、冰片1-3份、白矾1-3份。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S11)将所述各组份清洗后放入在砂锅中,加入没过成分的纯净水浸泡;
步骤S12)浸泡半小时后,加热水提2小时;
步骤S13)倒出水提液,再次加入同量纯净水,加热水提1.5小时;
步骤S14)合并两次水提液,静置后过滤上清液,浓缩至原1/3,制得原液。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S21)将所述成分混合均匀,取30 g,浸泡入1500 mL 50%乙醇中;
步骤S22)闪式提取3 min,滤除提取液;
步骤S23)提取液用0.22 μm微孔滤膜过滤,制得原液。
与传统制备方法相较,闪式提取法更加省时,且提取效果更好。
制备本发明的治疗痤疮组合物的方法,包括以下步骤:
步骤S31)购买所述成分主要提取物;
步骤S32)按其说明书,换算出生药量进行配比;
步骤S33)用换算后生药适宜量的50%乙醇溶解,制得原液。
案例1:王某,男,22岁。安徽亳州市人。
一诊2019年2月21日
主诉:鼻部反复出现脓疱三年余。
现病史:三年前开始于鼻尖部出现丘疹,潮红,瘙痒,渐延及鼻翼,逐渐形成脓疮,基底部红肿,时轻时重,缠绵不愈。脉弦滑,舌质红,苔稍黄。
中医诊断:口鼻疮
西医诊断:玫瑰痤疮
证属:风湿热邪、蕴阻肌肤
治则:祛风、除湿,杀虫、止痒。
本发明组合物,由以下组份制备而成:
苦参1-5份、百部1-6份、蛇床子0.5-5份、白鲜皮1-3份、侧柏叶1-4份、川楝子1-1.5份、防风1-4份、紫草1-5份、地肤子1-1.5份、土茯苓1-3份,另外加皂刺2-5份、蜂房1-3份,十剂水煎服。治疗前:鼻子潮红,鼻翼两侧起有严重红肿脓包,另有疼痛感。
二诊2019年3月16日
十剂药后,效果明显,鼻子潮红减退,仅有红色,疙瘩已平,自述有黄色分泌物。原方不变,巩固治疗。
三诊2020年1月15日
鼻子皮肤颜色仍不正常,鼻子仍有发红,发暗,毛孔粗大,有黑头。舌尖红,舌中苔微黄,舌质正常。原方不变,十剂水煎服,巩固治疗,以观后效。
四诊2020年2月17日
十剂药后。患者鼻子颜色恢复正常,红肿疙瘩痊愈。患者停中药,注意饮食,保证睡眠,精神愉快。
案例2:杜某某,男,64岁。甘肃兰州人。
一诊2020年11月13日
主诉:全身泛发皮疹,反复不愈已三年。
现病史:三年前冬季开始在两小腿起两小片集簇之丘疱疹,发痒,搔破后渗水,久治不愈,范围越见扩大。2019年冬渐播散至两前臂,一般入冬即见加重。11月14日,因为上呼吸道感染输液体后突然加重,皮疹多有丘疹,疱疹,斑片状等,红白相间,以痒为主,挠痕多,晚上奇痒无比,难以入睡。逐渐播散至胸、腹、背部。平时胃脘部疼痛,纳食不思,食后腹胀,大便日二三次,完谷不化,便溏,不敢食生冷水果。胸、腹及后背、四肢可见成片红斑、丘疹及集簇之丘疱疹,渗水糜烂,搔痕结痂,部分呈暗褐色,瘙痒无度。脉缓滑,舌质淡,苔薄白腻。
中医诊断:浸淫疮。
西医诊断:泛发性湿疹。
证属:风毒湿邪侵袭肌表,与湿热相搏所致,水湿内生,走串肌肤,浸淫成疮。
治则:疏风养血,清热除湿。
与案例1的区别在于:苦参2-4份、百部1-3份、蛇床子2-4份、白鲜皮1-3份、侧柏叶2.5-3.5份、防风2-4份、紫草2-4份、地肤子1-1.5份、蜂房2-3份、皂刺1-3份、薄荷4-6份、冰片1-3份、白矾1-3份,另外加滑石2-3份外用,共五剂,水煎服。
二诊2020年11月19日
症状缓解,不再发痒,皮疹颜色变淡,皮疹减少,再无发展。守方,原方不变,再服五剂,其他不变。
三诊2020年11月24日
全身皮疹已结痂,大多已退。有红斑片状脱屑,只有骶骨处皮疹发痒,其余部位场均无发痒,大有好转,嘱此五剂吃完后,停药10天,泡完澡后让痂自然脱落。舌淡苔白,脉细,由舌苔白转变淡白,舌质逐渐转变成红色,本次去去滑石,荆芥加入牛子,苦楝皮,加大去寒去湿之功。五剂,水煎服。
四诊2020年12月9日
患者全身皮疹已经全部退去,皮肤如常。已再无任何症状。痊愈。
案例3:张某,女,23岁,陕西省宝鸡人。
主诉:颜面部痤疮,反复发作三年余。
现病史:三年前秋季,因食辛辣刺激食物后,从面部开始出现红色皮疹,后形成黑色粉刺,挤后,有米粒样白色油脂排出,逐渐变为小脓疮,明确诊断痤疮,就诊后好转。后于南京学习,由于水土不服,劳累过度,上述症状加重,面部、口鼻周围、颊部均出现红色斑丘疹,逐渐形成粉刺,大小不等,最大的如黄豆大小,有脓头,隆起于皮肤,有痛感。曾多次就诊,内服中药,外用膏剂,效果不明显,迁延不愈,反复发作。患者精神差,情绪低落,纳食不思,食后腹胀,大便日二、三次不等,完谷不化,便溏。 脉缓滑,舌质淡,苔薄白腻。
中医诊断:粉刺。
西医诊断:痤疮。
证属:风热相搏,湿热内生,蕴蒸肌肤,瘀结生疮。
治则:疏风养血,清热除湿。
治疗:停药约半年,外用涂抹本发明组合,与案例1的区别在于:另加皂刺1-3份、蜂房0.5-1.5份。治疗痤疮的重要组合物的方法为:
步骤S11)将所述各组份清洗后放入在砂锅中,加入没过成分的纯净水浸泡;
步骤S12)浸泡半小时后,加热水提2小时;
步骤S13)倒出水提液,再次加入同量纯净水,加热水提1.5小时;
步骤S14)合并两次水提液,静置后过滤上清液,浓缩至原1/3,制得原液。
步骤S15)加入凝胶剂:水=1:50,以5%的比例加入原液,制得凝胶面膜放入瓶中备用。
面膜外用。效果明显,7天即起效,3个月后基本痊愈,跟踪一年未复发。
案例4:马某,男,37岁,甘肃兰州人。
主诉:头面部痤疮问题,反复发作近三年。
现病史:近三年,因多喝酒应酬,从面部开始出现红色皮疹,后形成黑黄色粉刺,使劲挤压则有米粒样白色油脂排出,且伴随有疼痛感,逐渐变为小脓疮,明确诊断痤疮,于刚就诊后有所好转。但由于工作等,劳累应酬则上述症状加重,面部、口鼻周围、颊部均出现红色斑丘疹,逐渐形成最大的如黄豆大小痤疮,有脓头,有痛感。曾多次就诊,内服中药,外用膏剂,效果不明显,迁延不愈,反复发作。患者精神差,情绪低落,纳食不思,食后腹胀。
中医诊断:粉刺。
西医诊断:痤疮。
与案例3的区别在于:苦参2-4份、百部1-3份、蛇床子2-4份、白鲜皮1-3份、侧柏叶2.5-3.5份、防风2-4份、紫草2-4份、地肤子1-1.5份、蜂房2-3份、皂刺1-3份、薄荷4-6份、冰片1-3份、白矾1-3份。
治疗痤疮的重要组合物的方法为:
步骤S21)将所述成分混合均匀,取30 g,浸泡入1500 mL 50%乙醇中;
步骤S22)闪式提取3 min,滤除提取液;
步骤S23)提取液用0.22 μm微孔滤膜过滤,制得原液。
步骤S24)加入凝胶剂:水=1:50,以5%的比例加入原液,制得凝胶面膜放入瓶中备用。
晚上涂抹,一周后明显减轻症状,痛感减轻;一月后基本痊愈。
案例5:何某某,男,21岁,四川人。主诉:头面部痤疮问题。应用本发明产品,每日晚涂抹一次,十日后面部痤疮基本痊愈,痛感减轻。与案例3的区别在于加入原液为6%。
案例6:纪某某,男,22岁,天津人。主诉:面部痤疮问题。应用本发明产品,每日晚涂抹一次,十日后面部痤疮基本痊愈,痛感减轻。与案例3的区别在于加入原液为6%。
案例7:张某,女,25岁,安徽芜湖人。主诉:过敏性玫瑰糠疹。应用本发明产品,每日晚涂抹一次,两周后面部玫瑰糠疹痊愈。与案例3的区别在于加入原液量为10%。
案例8:寇某某,女,48岁,江苏南京人。主诉:手臂蚊虫叮咬性过敏。应用本发明产品,涂抹两次,过敏肿包消敏痊愈。与案例4的区别在于:另加蜂蜜1-5份。
案例9:陈某某,女,21岁,宁夏人。主诉:面部痤疮,下巴嘴角处尤甚。应用本发明产品,涂抹两周,面部红肿明显减轻,下巴口角处明显肿包减少。与案例3的区别在于:另加蜂蜜1-10份。
案例10:邱某,女,21岁,福建人。主诉:面部螨虫过敏性痤疮。应用本发明产品,涂抹三天,面部过敏红斑明显减轻,一周后基本痊愈。与案例3的区别在于加入原液量为12%。
Claims (6)
1.一种治疗痤疮的组合物,其特征在于包含以下重量份的组份:
苦参1-5份、百部1-6份、蛇床子0.5-5份、白鲜皮1-3份、侧柏叶1-4份、川楝子1-1.5份、防风1-4份、紫草1-5份、地肤子1-1.5份、土茯苓1-3份。
2.根据权利要求1所述的治疗痤疮的组合物,其特征在于包含以下重量份的组份:
苦参2-4份、百部2-5份、蛇床子2-5份、白鲜皮1-3份、侧柏叶2-3份、川楝子1-1.5份、防风2-4份、紫草3-5份、地肤子1-1.5份、薄荷2-6份、冰片1-4份。
3.根据权利要求2所述的治疗痤疮的组合物,其特征在于包含以下重量份的组份:
苦参2-4份、百部1-3份、蛇床子2-4份、白鲜皮1-3份、侧柏叶2.5-3.5份、防风2-4份、紫草2-4份、地肤子1-1.5份、蜂房2-3份、皂刺1-3份、薄荷4-6份、冰片1-3份、白矾1-3份。
4.制备权利要求1-3任一项所述的治疗痤疮组合物的方法,其特征在于包括以下步骤:
步骤S11)将所述各组份清洗后放入在砂锅中,加入没过成分的纯净水浸泡;
步骤S12)浸泡半小时后,加热水提2小时;
步骤S13)倒出水提液,再次加入同量纯净水,加热水提1.5小时;
步骤S14)合并两次水提液,静置后过滤上清液,浓缩至原1/3,制得原液。
5.制备权利要求1-3任一项所述的治疗痤疮组合物的方法,其特征在于包括以下步骤:
步骤S21)将所述成分混合均匀,取30 g,浸泡入1500 mL 50%乙醇中;
步骤S22)闪式提取3 min,滤除提取液;
步骤S23)提取液用0.22 μm微孔滤膜过滤,制得原液。
6.制备权利要求1-3任一项所述的治疗痤疮组合物的方法,其特征在于包括以下步骤:
步骤S31)购买所述成分主要提取物;
步骤S32)按其说明书,换算出生药量进行配比;
步骤S33)用换算后生药适宜量的50%乙醇溶解,制得原液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211089689.0A CN115444912A (zh) | 2022-09-07 | 2022-09-07 | 一种治疗痤疮的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211089689.0A CN115444912A (zh) | 2022-09-07 | 2022-09-07 | 一种治疗痤疮的组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115444912A true CN115444912A (zh) | 2022-12-09 |
Family
ID=84302305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211089689.0A Pending CN115444912A (zh) | 2022-09-07 | 2022-09-07 | 一种治疗痤疮的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115444912A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780236A (zh) * | 2009-04-15 | 2010-07-21 | 李跃利 | 皮肤外用中药及制作方法 |
CN104857074A (zh) * | 2015-05-29 | 2015-08-26 | 吴建平 | 治疗痤疮的中药配方 |
CN105662996A (zh) * | 2016-01-27 | 2016-06-15 | 李如一 | 治疗月经相关性痤疮的中药面膜 |
CN106619908A (zh) * | 2015-11-04 | 2017-05-10 | 吴海燕 | 一种预防及治疗痤疮的外治药物 |
-
2022
- 2022-09-07 CN CN202211089689.0A patent/CN115444912A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101780236A (zh) * | 2009-04-15 | 2010-07-21 | 李跃利 | 皮肤外用中药及制作方法 |
CN104857074A (zh) * | 2015-05-29 | 2015-08-26 | 吴建平 | 治疗痤疮的中药配方 |
CN106619908A (zh) * | 2015-11-04 | 2017-05-10 | 吴海燕 | 一种预防及治疗痤疮的外治药物 |
CN105662996A (zh) * | 2016-01-27 | 2016-06-15 | 李如一 | 治疗月经相关性痤疮的中药面膜 |
Non-Patent Citations (1)
Title |
---|
王润妹: "自制止痒酊治疗皮肤病38例", 云南中医中药杂志 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101979041B (zh) | 一种治疗多种皮肤病的中药制剂 | |
CN102872241A (zh) | 一种用于治疗炎症性皮肤病的中药组合物及其制剂 | |
WO2018137319A1 (zh) | 大叶清香桂的应用,治疗皮肤病的中药膏剂、制备方法及其应用 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN101439114B (zh) | 一种治疗烧烫伤的中药及其制备方法 | |
CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN109674945A (zh) | 一种生肌止血消肿止痛愈疡的中药组合物及其制备方法 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN115444912A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
CN102488774B (zh) | 一种治疗口腔溃疡的中药散剂及其制备方法 | |
CN111920883A (zh) | 一种治疗带状疱疹的外用制剂及其制备方法 | |
CN105031596A (zh) | 一种治疗钱币状湿疹的软膏及其制备方法 | |
CN1286515C (zh) | 一种治疗囊肿的药物组合物 | |
CN111358927B (zh) | 蒲姜药物组合物及其应用 | |
CN110585379A (zh) | 一种皮炎治疗外敷药物 | |
CN103816381A (zh) | 一种治疗跌打损伤的药物及其制备方法 | |
CN108938757B (zh) | 一种治疗粉刺型痤疮的药物及其制备方法 | |
CN106266285A (zh) | 一种杀菌止痒、清热解毒的外用药物 | |
CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
CN102813854B (zh) | 一种治疗粉刺的中药膏 | |
CN104474272A (zh) | 一种治疗下肢溃疡的中药组合物 | |
CN105535211A (zh) | 一种用于治疗小儿湿疹的药物制剂及其用途 | |
CN105012483A (zh) | 一种治疗头部脂溢性皮炎的中药组合物及制备方法 | |
CN1329053C (zh) | 一种治疗小儿荨麻疹的外用剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221209 |
|
RJ01 | Rejection of invention patent application after publication |